CN Patent

CN103476372A — 舌下薄膜

Assigned to Pegasus Project Probe · Expires 2013-12-25 · 12y expired

What this patent protects

本发明特征在于多巴胺激动剂的舌下薄膜制剂，以及使用其治疗帕金森氏病、震颤、多动腿综合征、性功能障碍和抑郁障碍的方法。

USPTO Abstract

本发明特征在于多巴胺激动剂的舌下薄膜制剂，以及使用其治疗帕金森氏病、震颤、多动腿综合征、性功能障碍和抑郁障碍的方法。

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN103476372A
Jurisdiction: CN
Classification: —
Expires: 2013-12-25
Drug substance claim: No
Drug product claim: No
Assignee: Pegasus Project Probe
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.